Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020672 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Camilla Lodola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Genetics IGM-CNR 'Luigi Luca Cavalli-Sforza', Via Abbiategrasso 207, I-27100 Pavia, Italy. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, SARS-CoV-2, Nucleocapsid Proteins, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU-MUR PNRR INF-ACT, InFlaMe-HORIZON-HLTH-2024-Disease-08, Italian Association for Cancer Research.
Abstract (Originalsprache)
The SARS-CoV-2 nucleocapsid protein (Np) plays multifunctional roles in the viral life cycle. By interacting with host cellular proteins, Np regulates viral RNA transcription, replication, and immune evasion. It controls genome packaging and counteracts host RNA interference mediated antiviral responses through its RNA binding activity. Previous studies revealed a physical interaction between Np and DDX3X, a human DEAD-box RNA helicase that facilitates the replication of several viruses. This interaction enhances Np affinity for double-stranded RNA and inhibits DDX3X helicase activity. Since Np-RNA binding activity promotes ribonucleoprotein complex formation, targeting this interaction is a promising antiviral strategy. We generated truncated protein variants to define interaction regions between Np and DDX3X. Using AlphaFold modelling, we identified RecA2 as the key DDX3X domain involved in Np binding. Finally, to disrupt Np-RNA complex formation, we screened a small molecule library of putative binders of Np N-terminal region and identified two candidate inhibitors for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Genetics IGM-CNR 'Luigi Luca Cavalli-Sforza', Via Abbiategrasso 207, I-27100 Pavia, Italy.
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, I-53100 Siena, Italy.
- Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy.
ORCID-Profile: Camilla Lodola, Maria Michela Pallotta, Fabrizio Manetti, Paolo Governa, Massimiliano Secchi
Förderung
- EU-MUR PNRR INF-ACT
- InFlaMe-HORIZON-HLTH-2024-Disease-08
- Italian Association for Cancer Research
- National Research Council, italy
Zitieren
APA
Lodola, C., Pallotta, M. M., Manetti, F., Governa, P., Crespan, E., Maga, G., & Secchi, M. (2026). Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020672
Vancouver
Lodola C, Pallotta MM, Manetti F, Governa P, Crespan E, Maga G, et al. Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020672
BibTeX
@article{Lodola2026,
author = {Lodola, Camilla and Pallotta, Maria Michela and Manetti, Fabrizio and Governa, Paolo and Crespan, Emmanuele and Maga, Giovanni and Secchi, Massimiliano},
title = {Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020672}
}
EUVIMED